非索非那定
医学
慢性特发性荨麻疹
交叉研究
慢性荨麻疹
皮肤病科
药理学
安慰剂
替代医学
病理
作者
Hideaki Tanizaki,Yosuke Yamamoto,Satoshi Nakamizo,Atsushi Otsuka,Yoshiki Miyachi,Kenji Kabashima
出处
期刊:Pharmacology
[Karger Publishers]
日期:2015-01-01
卷期号:95 (1-2): 32-35
被引量:4
摘要
Olopatadine is one of the second-generation H<sub>1</sub> antihistamines that were used for treating allergic disorders initially in Asia, and now also in Western countries. Whereas several trials compared the efficacy on chronic urticaria among second-generation H<sub>1</sub> antihistamines, no study has directly compared the clinical efficacy between olopatadine and other H<sub>1</sub> antihistamines in patients with chronic idiopathic urticaria (CIU). In this study, we address this issue for the first time and conclude that olopatadine is a good candidate for the treatment of CIU.
科研通智能强力驱动
Strongly Powered by AbleSci AI